title: [Long-term outcome of nephrotic syndrome due to primary membranous nephropathy].
authors.forename: S
authors.initials: S
authors.lastname: Fujimoto
authors.forename: Y
authors.initials: Y
authors.lastname: Yamamoto
authors.forename: O
authors.initials: O
authors.lastname: Wakisaka
authors.forename: S
authors.initials: S
authors.lastname: Hisanaga
authors.forename: J
authors.initials: J
authors.lastname: Miyata
authors.forename: K
authors.initials: K
authors.lastname: Tanaka
mesh_terms: D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D015433:Glomerulonephritis, Membranous / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000209:etiology; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D012074:Remission Induction
chemical_list: D003520:Cyclophosphamide; D011239:Prednisolone; D001379:Azathioprine